Diaceutics PLC (FRA:7DC)
Germany flag Germany · Delayed Price · Currency is EUR
1.790
+0.080 (4.68%)
At close: Jan 30, 2026

Diaceutics Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
34.432.1623.719.513.9412.7
Revenue Growth (YoY)
31.83%35.69%21.51%39.88%9.82%-5.55%
Cost of Revenue
4.783.893.992.761.713.23
Gross Profit
29.6328.2719.7116.7412.239.46
Selling, General & Admin
31.8530.7422.7816.2811.8810.02
Other Operating Expenses
-0.18-0.02-0.06-0.11-0.2-0.28
Operating Expenses
31.6830.7322.7216.1711.689.73
Operating Income
-2.05-2.46-3.020.580.55-0.27
Interest Expense
-0.06-0.05-0.07-0.12-0.09-0.05
Interest & Investment Income
0.450.60.650.11-0.03
Other Non Operating Income (Expenses)
----0--
EBT Excluding Unusual Items
-1.66-1.91-2.440.560.46-0.29
Merger & Restructuring Charges
------0.39
Pretax Income
-1.66-1.91-2.440.560.46-0.68
Income Tax Expense
-0.14-0.21-0.69-0.16-0.1-0.95
Net Income
-1.52-1.7-1.750.720.560.26
Net Income to Common
-1.52-1.7-1.750.720.560.26
Net Income Growth
---29.05%113.31%-33.92%
Shares Outstanding (Basic)
848484848478
Shares Outstanding (Diluted)
848484868578
Shares Change (YoY)
0.19%0.27%-2.16%1.35%9.14%21.29%
EPS (Basic)
-0.02-0.02-0.020.010.010.00
EPS (Diluted)
-0.02-0.02-0.020.010.010.00
EPS Growth
---27.29%94.55%-45.29%
Free Cash Flow
0.010.551.194.910.010.12
Free Cash Flow Per Share
-0.010.010.06-0.00
Gross Margin
86.12%87.91%83.15%85.83%87.73%74.53%
Operating Margin
-5.96%-7.63%-12.73%2.95%3.94%-2.13%
Profit Margin
-4.42%-5.30%-7.37%3.71%4.02%2.07%
Free Cash Flow Margin
0.03%1.71%5.00%25.17%0.04%0.91%
EBITDA
1.330.550.12.081.520.43
EBITDA Margin
3.85%1.72%0.43%10.64%10.88%3.35%
D&A For EBITDA
3.383.013.121.50.970.7
EBIT
-2.05-2.46-3.020.580.55-0.27
EBIT Margin
-5.96%-7.63%-12.73%2.95%3.94%-2.13%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.